Genmab (GMAB)

36.72 2.74%
03:12 pm EDT; Powered by Koyfin
Pros
Revenue growth higher than the industry and sector averages
Forward P/E ratio low relative to industry peers
Forward PEG ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Cons
High short interest

Pros

  1. GMAB quarterly revenue growth was 34.00%, higher than the industry and sector average revenue growth (3.01% and 6.10%, respectively). See GMAB revenue growth chart.
  2. GMAB forward P/E ratio is 14.34, which is low compared to its industry peers’ P/E ratios. See GMAB forward P/E ratio chart.
  3. GMAB PEG ratio (P/E adjusted for growth) is 0.19, which is low compared to its industry peers’ PEG ratios. See GMAB PEG chart.
  4. GMAB average analyst rating is Buy. See GMAB analyst rating chart.
  5. GMAB average analyst price target ($38.92) is above its current price ($35.13). See GMAB price target chart.

Cons

  1. GMAB short interest (days to cover the shorts) ratio is 3.5. The stock garners more short interest than the average industry, sector or S&P 500 stock. See GMAB short interest ratio chart.